Key Highlights

Risk & Performance

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Phase 3

3(75.0%)

N/A

1(25.0%)

4Total

Phase 3(3)

N/A(1)

Loading network data...

Showing 5 of 5 trials

Comparison of Prophylactic Photobiomodulation Protocols in Chemoinduced Oral Mucositis in Oncology Patients

Role: collaborator

Carvedilol Effect in Preventing Chemotherapy - Induced Cardiotoxicity

Role: collaborator

Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme

Role: collaborator

Resource-Sparing Curative Treatment for Rectal Cancer

Role: collaborator

Hearing Loss and Complaint in Patients With Head and Neck Cancer Treated With Radiotherapy

Role: lead

All 5 trials loaded